等待开盘 11-18 09:30:00 美东时间
-0.880
-0.28%
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
Morgan Stanley analyst Cameron Mansson-Perrone maintains MSG Knickerbockers (NYSE:MSGK) with a Overweight and lowers the price target from $450 to $375.
11-11 01:14
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Truist Securities analyst Richard Newitter upgraded Edwards Lifesciences Corp (NYSE:EW) from Hold...
11-04 21:59
Wolfe Research analyst Peter Supino upgrades MSG Knickerbockers (NYSE:MSGK) from Peer Perform to Outperform.
11-04 18:32
今日重点评级关注:BTIG:维持Cullinan Therapeutics"买入"评级,目标价从40美元升至41美元;Rosenblatt:维持SK海力士"买入"评级,目标价从320美元升至400美元
10-29 12:30
Guggenheim analyst Curry Baker maintains MSG Knickerbockers (NYSE:MSGK) with a Buy and lowers the price target from $584 to $445.
10-28 21:30